Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BostonSight® Specialty Lenses

K-Number: K241571 · 2024-08-14

ApplicantBoston Foundation For Sight, Inc. D/B/A Bostonsight
Decision Date2024-08-14
Product CodeHQD
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

BostonSight® Specialty Lenses is a medical device manufactured by Boston Foundation For Sight, Inc. D/B/A Bostonsight. It received FDA 510(k) clearance on 2024-08-14 under approval number K241571. The device is classified under product code HQD. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BostonSight® Specialty Lenses?

BostonSight® Specialty Lenses is a medical device that received FDA 510(k) clearance on 2024-08-14. It is manufactured by Boston Foundation For Sight, Inc. D/B/A Bostonsight. The 510(k) number is K241571.

When was BostonSight® Specialty Lenses approved by the FDA?

BostonSight® Specialty Lenses received FDA 510(k) clearance on 2024-08-14, under approval number K241571.

What company makes BostonSight® Specialty Lenses?

BostonSight® Specialty Lenses is manufactured by Boston Foundation For Sight, Inc. D/B/A Bostonsight.

What is the FDA product code for BostonSight® Specialty Lenses?

The FDA product code for BostonSight® Specialty Lenses is HQD.

Related Devices (Code: HQD)

K162005Acuity 100 (hexafocon A) Rigid Gas Permeable Contact LensAcuity Polymers, Inc. K153714SynergEyes A&M (paflufocon D hem-iberfilcon A) Hybrid Daily Wear Contact Lens, SynergEyes KC (paflufocon D hem-iberfilcon A) Hybrid Daily Wear Contact Lens, SynergEyes PS (paflufocon D hem-iberfilcon A) Hybrid Daily Wear Contact Lens, SynergEyes SiH (petrafocon A hem-larafilcon A) Hybrid Daily Wear Contact Lens, SynergEyes UltraHealth for Keratoconus (petrafocon A hem-larafilcon A) Hybrid Daily Wear CoSynergeyes, Inc. K161100Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact LensesContamac, Ltd. K160938SynergEyes SiH with Hydra-PEG(petrafocon A hem-larafilcon A) Hybrid Daily Wear LensSynergeyes, Inc. K161461BostonSight PD Prosthetic DeviceBostonsight K152724EYEPRINTPRO (ROFLUFOCON D) SCLERAL GP LENSESAdvanced Vision Technologies

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑